✦ LIBER ✦

Dapagliflozin has no effect on markers of bone formation and resorption or bone mineral density in patients with inadequately controlled type 2 diabetes mellitus on metformin

✍ Scribed by Ö. Ljunggren; J. Bolinder; L. Johansson; J. Wilding; A. M. Langkilde; C. D. Sjöström; J. Sugg; S. Parikh

Book ID: 115185099
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 883 KB
Volume: 14
Category: Article
ISSN: 1462-8902
DOI: 10.1111/j.1463-1326.2012.01630.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The effect of semelil (angipars®) on bon

The effect of semelil (angipars®) on bone resorption and bone formation markers in type 2 diabetic patients

✍ Shirin Hasani-Ranjbar, Zahra Jouyandeh, Mostafa Qorbani, Mahbubeh Hemmatabadi, B 📂 Article 📅 2012 🏛 Springer (Biomed Central Ltd.) 🌐 English ⚖ 162 KB

89 THE EFFECT OF SEMELIL (ANGIPARS) ON B

89 THE EFFECT OF SEMELIL (ANGIPARS) ON BONE RESORPTION AND BONE FORMATION MARKERS IN TYPE 2 DIABETIC PATIENTS

✍ Ranjbar, S. Hassani; Jouyandeh, Z.; Larijani, B.; Hemmatabadi, M.; Ghorbani, M. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 69 KB

Durability of glycaemic efficacy over 2

Durability of glycaemic efficacy over 2 years with dapagliflozin versus glipizide as add-on therapies in patients whose type 2 diabetes mellitus is inadequately controlled with metformin

✍ Nauck, M. A.; Del Prato, S.; Durán-García, S.; Rohwedder, K.; Langkilde, A. M.; 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 768 KB

Effects of Colesevelam, Rosiglitazone, o

Effects of Colesevelam, Rosiglitazone, or Sitagliptin on Glycemic Control and Lipid Profile in Patients with Type 2 Diabetes Mellitus Inadequately Controlled by Metformin Monotherapy

✍ Rigby, Scott; Handelsman, Yehuda; Lai, Yu-Ling; Abby, Stacey; Tao, Ben; Jones, M 📂 Article 📅 2010 🏛 American Association of Clinical Endocrinologists 🌐 English ⚖ 308 KB

A 2-year Follow-up Study on Bone Mineral

A 2-year Follow-up Study on Bone Mineral Density and Markers of Bone Turnover in Patients with Long-standing Insulin-Dependent Diabetes Mellitus

✍ T. Miazgowski; S. Czekalski 📂 Article 📅 1998 🏛 Springer-Verlag 🌐 English ⚖ 41 KB

Nateglinide or gliclazide in combination

Nateglinide or gliclazide in combination with metformin for treatment of patients with type 2 diabetes mellitus inadequately controlled on maximum doses of metformin alone: 1-year trial results

✍ S. Ristic; C. Collober-Maugeais; F. Cressier; P. Tang; E. Pecher 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB